ozanimod: Clinical Trials

6 trials of ozanimod, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

6 terminated. 6 Phase 3, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	6	Terminated 6
Phase 2	1	Terminated 1

Follow ozanimod: new trials by email Literature Review of ozanimod trials Research Report on ozanimod

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy Ozanimod - Crohn Disease	Phase 2 / Phase 3	Terminated	Bristol-Myers Squibb	5	2023-08-22	2025-04-22
A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC) Ozanimod, Placebo - Ulcerative Colitis	Phase 3	Terminated	Bristol-Myers Squibb	131	2022-12-09	2025-03-26
Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) RPC-1063 - Multiple Sclerosis	Phase 3	Terminated	Celgene	188	2020-01-16	2025-06-12
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease Ozanimod - Crohn Disease	Phase 3	Terminated	Celgene	854	2018-08-24	2025-09-17
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease Ozanimod, Placebo - Crohn Disease	Phase 3	Terminated	Celgene	550	2018-06-27	2025-10-09
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease Ozanimod, Placebo - Crohn Disease	Phase 3	Terminated	Celgene	625	2018-02-27	2025-11-04

Conditions studied

Sponsors

Countries

Results publications

NIH funding